Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Introduction

GlobalData’s new report, “Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery” provides key market data on the Russian Federation Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Russian Federation Diabetes Care Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Eli Lilly and Company, LifeScan, Inc., Novo Nordisk A/S, Becton, Dickinson and Company and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Russian Federation Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
F. Hoffmann-La Roche Ltd.
Sanofi
Eli Lilly and Company
LifeScan, Inc.
Novo Nordisk A/S
Becton, Dickinson and Company
Bayer HealthCare AG
Medtronic, Inc.
Abbott Laboratories
Ypsomed Holding AG
NIPRO CORPORATION
Terumo Corporation
Animas Corporation
[Studien Infos ausblenden]

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What is This Report About? 8
3 Diabetes Care Devices In Russian Federation 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 10
3.3 Diabetes Care Devices Market, Russian Federation, Revenue Mix ($m), 2010 11
3.4 Diabetes Care Devices Market, Russian Federation, Category Contribution (%), 2010 12
3.5 Diabetes Care Devices, Russian Federation, Category Volume (Units), 2003-2017 18
3.6 Diabetes Care Devices, Russian Federation, Company share (2009-2010) 21
4 Glucose Monitoring In Russian Federation 23
4.1 Glucose Monitoring, Market Segmentation 23
4.2 Glucose Monitoring Market, Russian Federation, Revenue Mix ($m), 2010 24
4.3 Glucose Monitoring Market, Russian Federation, Segment Contribution (%), 2010 25
4.4 Glucose Monitoring Overall Revenue (2003-2017) 26
4.4.1 Blood Glucose Meters Revenue (2003-2017) 30
4.5 Glucose Monitoring Overall Volume (2003-2017) 34
4.5.1 Blood Glucose Meters Volume (2003-2017) 38
4.6 Glucose Monitoring Average Price (2003-2017) 41
4.7 Glucose Monitoring Distribution Share (2009-2010) 42
4.8 Glucose Monitoring, Russian Federation, Company share (2009-2010) 43
5 Insulin Delivery In Russian Federation 45
5.1 Insulin Delivery, Market Segmentation 45
5.2 Insulin Delivery Market, Russian Federation, Revenue Mix ($m), 2010 46
5.3 Insulin Delivery Market, Russian Federation, Segment Contribution (%), 2010 47
5.4 Insulin Delivery Overall Revenue (2003-2017) 48
5.4.1 Insulin Pens Revenue (2003-2017) 52
5.4.2 Insulin Pumps Revenue (2003-2017) 56
5.5 Insulin Delivery Overall Volume (2003-2017) 58
5.5.1 Insulin Pens Volume (2003-2017) 62
5.5.2 Insulin Pumps Volume (2003-2017) 65
5.6 Insulin Delivery Average Price (2003-2017) 67
5.7 Insulin Delivery Distribution Share (2009-2010) 68
5.8 Insulin Delivery, Russian Federation, Company share (2009-2010) 69
6 Overview of Key Companies in Russian Federation Diabetes Care Devices Market 71
6.1 F. Hoffmann-La Roche Ltd. 71
6.1.1 Company Overview 71
6.1.2 Share in the Russian Federation Diabetes Care Devices Market 71
6.2 Sanofi 72
6.2.1 Company Overview 72
6.2.2 Share in the Russian Federation Diabetes Care Devices Market 72
6.3 Eli Lilly and Company 73
6.3.1 Company Overview 73
6.3.2 Share in the Russian Federation Diabetes Care Devices Market 73
6.4 LifeScan, Inc. 74
6.4.1 Company Overview 74
6.4.2 Share in the Russian Federation Diabetes Care Devices Market 74
6.5 Novo Nordisk A/S 75
6.5.1 Company Overview 75
6.5.2 Share in the Russian Federation Diabetes Care Devices Market 75
6.6 Becton, Dickinson and Company 76
6.6.1 Company Overview 76
6.6.2 Share in the Russian Federation Diabetes Care Devices Market 76
6.7 Bayer HealthCare AG 77
6.7.1 Company Overview 77
6.8 Medtronic, Inc. 77
6.8.1 Company Overview 77
6.9 Abbott Laboratories 78
6.9.1 Company Overview 78
6.10 Ypsomed Holding AG 78
6.10.1 Company Overview 78
6.11 NIPRO CORPORATION 78
6.11.1 Company Overview 78
6.12 Terumo Corporation 79
6.12.1 Company Overview 79
6.13 Animas Corporation 79
6.13.1 Company Overview 79
7 Diabetes Care Devices Market Pipeline Products 80
8 Appendix 84
8.1 Definitions of Markets Covered in the Report 85
8.1.1 Diabetes Care Devices 85
8.2 Research Methodology 88
8.3 Secondary Research 88
8.4 Primary Research 89
8.5 Models 89
8.6 Forecasts 90
8.7 Expert Panels 90
8.8 GlobalData Consulting 90
8.9 Currency Conversion 91
8.10 Contact Us 91
8.11 Disclaimer 91
[Inhaltsverzeichnis ausblenden]

1.1 List of Tables
Table 1: Diabetes Care Devices, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 10
Table 2: Diabetes Care Devices Market, Russian Federation, Category Contribution (%), 2010 12
Table 3: Diabetes Care Devices, Russian Federation, Cross-Segment Analysis, 2003-2017 13
Table 4: Diabetes Care Devices, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 15
Table 5: Diabetes Care Devices, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 17
Table 6: Diabetes Care Devices, Russian Federation, Category Volume (Units), 2003-2017 18
Table 7: Diabetes Care Devices, Russian Federation, Category Volume (Units), Historic, 2003-2010 19
Table 8: Diabetes Care Devices, Russian Federation, Category Volume (Units), Forecast, 2010-2017 20
Table 9: Diabetes Care Devices, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 22
Table 10: Glucose Monitoring Market, Russian Federation, Segment Contribution (%), 2010 25
Table 11: Glucose Monitoring, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 27
Table 12: Glucose Monitoring, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 29
Table 13: Blood Glucose Meters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 31
Table 14: Blood Glucose Meters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 33
Table 15: Glucose Monitoring, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 35
Table 16: Glucose Monitoring, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 37
Table 17: Blood Glucose Meters, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 39
Table 18: Blood Glucose Meters, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 40
Table 19: Glucose Monitoring, Russian Federation, Average Price ($), Historic, 2003-2010 41
Table 20: Glucose Monitoring, Russian Federation, Average Price ($), Forecast, 2010-2017 41
Table 21: Glucose Monitoring, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 42
Table 22: Glucose Monitoring, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 44
Table 23: Insulin Delivery Market, Russian Federation, Segment Contribution (%), 2010 47
Table 24: Insulin Delivery, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 49
Table 25: Insulin Delivery, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 51
Table 26: Insulin Pens, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 53
Table 27: Insulin Pens, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 55
Table 28: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Revenue ($m), USD Actual, Historic, 2003-2010 56
Table 29: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Revenue ($m), USD Actual, Forecast, 2010-2017 57
Table 30: Insulin Delivery, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 59
Table 31: Insulin Delivery, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 61
Table 32: Insulin Pens, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Table 33: Insulin Pens, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64
Table 34: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Volume (Units), Historic, 2003-2010 65
Table 35: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Volume (Units), Forecast, 2010-2017 66
Table 36: Insulin Delivery, Russian Federation, Average Price ($), Historic, 2003-2010 67
Table 37: Insulin Delivery, Russian Federation, Average Price ($), Forecast, 2010-2017 67
Table 38: Insulin Delivery, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 68
Table 39: Insulin Delivery, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 70
Table 40: Diabetes Care Devices Market Pipeline Products 80
Table 41: USD to Local Currency, Russian Federation, Average Actual Rate 2003-2010 91
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 9
Figure 2: Diabetes Care Devices, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 10
Figure 3: Diabetes Care Devices Market, Russian Federation, Revenue Mix ($m), 2010 11
Figure 4: Diabetes Care Devices Market, Russian Federation, Category Contribution (%), 2010 12
Figure 5: Diabetes Care Devices, Russian Federation, Cross-Segment Analysis, 2003-2017 13
Figure 6: Diabetes Care Devices, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Figure 7: Diabetes Care Devices, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 16
Figure 8: Diabetes Care Devices, Russian Federation, Category Volume (Units), 2003-2017 18
Figure 9: Diabetes Care Devices, Russian Federation, Category Volume (Units), Historic, 2003-2010 19
Figure 10: Diabetes Care Devices, Russian Federation, Category Volume (Units), Forecast, 2010-2017 20
Figure 11: Diabetes Care Devices, Russian Federation, Company share (%), 2010 21
Figure 12: Glucose Monitoring, Market Segmentation 23
Figure 13: Glucose Monitoring Market, Russian Federation, Revenue Mix ($m), 2010 24
Figure 14: Glucose Monitoring Market, Russian Federation, Segment Contribution (%), 2010 25
Figure 15: Glucose Monitoring, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 26
Figure 16: Glucose Monitoring, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 28
Figure 17: Blood Glucose Meters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 30
Figure 18: Blood Glucose Meters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 32
Figure 19: Glucose Monitoring, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 34
Figure 20: Glucose Monitoring, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 36
Figure 21: Blood Glucose Meters, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 38
Figure 22: Blood Glucose Meters, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 40
Figure 23: Glucose Monitoring, Russian Federation, Company share (%), 2010 43
Figure 24: Insulin Delivery, Market Segmentation 45
Figure 25: Insulin Delivery Market, Russian Federation, Revenue Mix ($m), 2010 46
Figure 26: Insulin Delivery Market, Russian Federation, Segment Contribution (%), 2010 47
Figure 27: Insulin Delivery, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 48
Figure 28: Insulin Delivery, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 50
Figure 29: Insulin Pens, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 52
Figure 30: Insulin Pens, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 54
Figure 31: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Revenue ($m), USD Actual, Historic, 2003-2010 56
Figure 32: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Revenue ($m), USD Actual, Forecast, 2010-2017 57
Figure 33: Insulin Delivery, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 58
Figure 34: Insulin Delivery, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 60
Figure 35: Insulin Pens, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 62
Figure 36: Insulin Pens, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64
Figure 37: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Volume (Units), Historic, 2003-2010 65
Figure 38: Insulin Pumps (Traditional Insulin Pumps), Russian Federation, Volume (Units), Forecast, 2010-2017 66
Figure 39: Insulin Delivery, Russian Federation, Company share (%), 2010 69
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%),Russian Federation Diabetes Care Devices Market, 2010 71
Figure 41: Sanofi, Company Share (%),Russian Federation Diabetes Care Devices Market, 2010 72
Figure 42: Eli Lilly and Company, Company Share (%),Russian Federation Diabetes Care Devices Market, 2010 73
Figure 43: LifeScan, Inc., Company Share (%),Russian Federation Diabetes Care Devices Market, 2010 74
Figure 44: Novo Nordisk A/S, Company Share (%),Russian Federation Diabetes Care Devices Market, 2010 75
Figure 45: Becton, Dickinson and Company, Company Share (%),Russian Federation Diabetes Care Devices Market, 2010 76
[Tabellenverzeichnis ausblenden]